MOORESTOWN, N.J., Jan. 12, 2017 -- Tabula Rasa HealthCare Corporation (NASDAQ:TRHC), announces that a leading, multi-state, Program of All-Inclusive Care for the Elderly (PACE) provider has signed a three-year agreement for medication care management services. The organization selected TRHC to help enhance quality, efficiency, and reduce total costs.
According to the Centers for Medicare and Medicaid Studies, PACE is a Medicare program for people over age 55 living with disabilities. The program provides community-based care and services to people who otherwise need nursing home care. PACE was created to provide flexibility to meet the health care needs of older Americans in order to help them continue living in their communities. All of Medicare and Medicaid’s services are included for PACE enrollees, along with other services that are part of the PACE Interdisciplinary Team’s care plan. Coverage for prescription drugs, primary care, transportation, home care, hospital visits, and nursing home stays, whenever necessary, are included for those enrolled in PACE.
The Agreement calls for TRHC to provide medication care management services, including comprehensive Medication Risk Mitigation®, and science-driven, reminder-packaging pharmacy services for their PACE participants to help reduce the risk of adverse drug events while improving adherence.
“TRHC continues to advance the practice and science of medication risk mitigation through our personalized medicine approach,” said Chairman and CEO Calvin H. Knowlton, PhD. “We are pleased to have formalized the collaboration with this organization with the goal of optimizing outcomes for these frail-elderly individuals.”
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Since 2011, TRHC has focused on optimizing outcomes for PACE and other healthcare organizations through its unique Medication Risk Mitigation software and Medication Decision Support and Adherence tools that personalize each participants medication regimen. For more information, please visit: www.TRHC.com.
Contact: Media TRHC Dianne Semingson [email protected] T: 215-870-0829 Investors Bob East or Asher Dewhurst Westwicke Partners [email protected] T : 443-213-0500


7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland 



